• 1
    Peters DH, Sorkin EM. Zonisamide—a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs 1993;45:76087.
  • 2
    Patsalos PN, Sander JWAS. Newer antiepileptic drugs—towards an improved risk-benefit ratio. Drug Safety 1994;11:3747.
  • 3
    Yagi K, Seino M. Methodological requirements for clinical trials in refractory epilepsies—our experience with zonisamide. Prog Neuropsychopharmacol Biol Psychiatry 1992; 16:7985.
  • 4
    Hikima A, Shimizu N, Takizawa N. Treatment of West syndrome with zonisamide: 13 case reports (in Japanese) [Abstract]. No To Hattatsu 1993;25(suppl):5132.
  • 5
    YagiK, SekiT, eds. Zonisamide in epilepsy therapy. Remarkable improvement: 100 cases (in Japanese). Tokyo : Sozo Shuppan, 1994.
  • 6
    Yanagihara K, Imai K, Otani K, Futagi Y. The effect of zonisamide in West syndrome. (in Japanes). No To Hattatsu 1995;27:5002.
  • 7
    Snead OC III. Treatment of infantile spasms. Pediatr Neurol 1990;6:14750.
  • 8
    Watanabe K. Medical treatment of West syndrome in Japan. J Child Neurol 1995;10:1437.
  • 9
    Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, Menander KB. Valproic acid hepatic fatalities: a retrospective review. Neurology 1987;37:37985.
  • 10
    Appleton RE. Vigabatrin in the management of generalized seizures in children. Seizure 1995;4:458.
  • 11
    Veggiotti P, Cieuta C, Rey E, Dulac O. Lamotrigine in infantile spasms [Letter]. Lancet 1994;344:13756.
  • 12
    Hurst DL, Rolan TD. The use of felbamate to treat infantile spasms. J Child Neurol 1995; 10:1346.
  • 13
    Fukushima K, Yagi K, Seino M, et al. A clinical phase I1 study of a new antiepileptic drug, zonisamide on the refractory epilepsy in childhood (in Japanese). Jpn J Pediatr 1987;40:338997.